✓ Editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Clinical Reference

Dosing & Pharmacology

Released: Last reviewed:

Wegovy: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly. Ozempic: 0.25 → 0.5 → 1.0 → 2.0 mg weekly. Rybelsus: 3 → 7 → 14 mg daily oral.

Clinical reference
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 20, 2026 · This page is informational and does not constitute medical advice.

Overview

Wegovy: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly. Ozempic: 0.25 → 0.5 → 1.0 → 2.0 mg weekly. Rybelsus: 3 → 7 → 14 mg daily oral.

Related clinical pages

Key facts, checked November 20, 2026

According to the Wegovy label, Wegovy is injected once weekly, starting at 0.25 mg for four weeks and stepping up every four weeks to a maintenance dose of 2.4 mg (or 1.7 mg) in adults and 2.4 mg in patients 12 and older. Saxenda is a once-daily injection (Saxenda label), and Zepbound a once-weekly one (Zepbound label). For compounded multi-dose vials, FDA’s page on unapproved GLP-1 drugs says to discard the vial 28 days after first use even if medication remains, which on a weekly schedule means four doses per vial.